Biomarker-guided monitoring of treatment with mesenchymal stem cells in liver disease
Analyze the efficacy of mesenchymal stem cell (MSC) therapy in liver disease via biomarker-guided monitoring. This article explores novel biomarkers to track treatment response, improving patient stratification and optimizing therapeutic outcomes. Learn about the latest advancements in MSC therapy for liver disease.